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Adjunctive primary stenting of Zenith endograft
limbs during endovascular abdominal aortic
aneurysm repair: Implications for limb patency
Nayan Sivamurthy, MD, Darren B. Schneider, MD, Linda M. Reilly, MD, Joseph H. Rapp, MD,
Herman Skovobogatyy, MD, and Timothy A. M. Chuter, MD, San Francisco, Calif
Objective: Endograft limb occlusion is an infrequent but serious complication of endovascular abdominal aortic aneurysm
(AAA) repair. The insertion of additional stents within the endograft limb may prevent future occlusion. This study
evaluates limb patency with and without adjunctive stenting of endograft limbs at the time of endovascular AAA repair.
Methods: We performed a retrospective review of 248 patients who underwent endovascular abdominal aortic aneurysm
repair with the Zenith AAA endovascular graft between 1999 and 2004. Among these patients, two groups were
identified: 64 patients with adjunctive stents placed in 85 limbs and 184 patients without additional bare stent placement
in endograft limbs at the time of endovascular AAA repair.
Results:Women comprised 23% of stented and 11% of unstented patients (P .02). The mean length of follow-up in the
stented and unstented groups was 2.0 years. There were 13 instances of limb thrombosis in 13 patients (5.2% of patients,
2.7% of limbs), all in the unstented group. No limb occlusions occurred in the presence of adjunctive bare metal stents.
Seventy-three percent of the occlusions occurred <6 months of endovascular AAA repair. Two patients (15%) had no
symptoms of lower-extremity ischemia despite graft limb occlusion and did not undergo intervention. The others
underwent thrombectomy (n  2), thrombectomy with bare stent placement (n  3), femoral-femoral bypass (n  4),
thrombolysis (n  1), and thrombolysis with bare stent placement (n  1). Of the seven who underwent thrombectomy
or thrombolysis, three had no additional stents placed at the secondary procedure, and two of these three went on to
rethrombose. By life-table analysis, primary patency at 3 years in the stented and nonstented limbs was 100%  0% and
94%  3%, respectively (P  .05).
Conclusions: The intraoperative insertion of additional bare metal stents appeared to eliminate the risk of thrombosis and
was without complication. Of the 85 stented limbs in this series, not one occluded. The overall rate of limb thrombosis
was low, with most limb occlusions occurring <6 months of stent-graft insertion, and would probably have been even
lower had we been able to identify all high-risk cases for prophylactic adjunctive stenting. Limb occlusion denotes an
underlying problemwith the graft, which if left untreated after thrombectomy or thrombolysis will lead to rethrombosis.
Postoperative imaging was of little value in detecting impending limb occlusion. Based on these findings, we believe one
should identify and stent any limbs that appear to be at risk for thrombosis, but this study lacks the data to predict which
limbs need stenting. (J Vasc Surg 2006;43:662-70.)Endovascular aneurysm repair has many short-term
advantages over open surgery,1,2 but long-term durability
is marred by late complications, many of which require
reintervention.3,4 The rates of graft limb thrombosis vary
according to the design of the stent-graft, with unsup-
ported limbs showing the highest rates.3,5-9 Fully stented
limbs fare better, but the most widely used systems still have
reported limb thrombosis rates of 3% to 5%.
Much has been written on the treatment of graft limb
thrombosis,3,7,10,11 but little regarding its prevention.5
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662The goal of this study was to evaluate the role of adjunctive
bare stenting of endograft limbs in the prevention of graft
limb occlusion.
METHODS
We performed a retrospective review of patients at
University of California, San Francisco (UCSF) Medical
Center who underwent endovascular abdominal aortic an-
eurysm (AAA) repair with the standard bifurcated Zenith
AAA endovascular graft (Cook Inc, Bloomington, Ind)
between February 1999 and June 2004. This study was
approved by the UCSF Institutional Review Board.
We identified 323 patients. Of these, 75 lacked suffi-
cient imaging and were excluded, and 248 patients had
sufficient intraoperative and postoperative imaging to show
additional stents within the limbs, identify the probable
indications for stenting, and determine subsequent limb
patency. Two groups were identified: patients with and
without additional bare stent placement in endograft limbs
at the time of endovascular AAA repair. We collected
information on demographics, existing comorbid condi-
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interventions.
After standard deployment of the Zenith AAA endo-
vascular graft, we removed all guidewires and performed
multiplanar angiography to assess device placement, aneu-
rysm exclusion, limb angulation, and patency. Cases of
possible luminal compromise were generally investigated
further by injecting contrast into one limb at a time in the
ipsilateral anterior oblique view.
When we saw narrowing of the graft limb in association
with angulation (kinking), we implanted a Wallstent (Bos-
ton Scientific Co, Natick, Mass), dilated the area by using
an angioplasty balloon, and repeated the angiography.
When we saw narrowing of the graft limb in association
with external compression at the aortic bifurcation, we
implanted one (or more) Palmaz stents (Cordis Co,Miami,
Fla). Under these circumstances, the two limbs often over-
lapped, and angiographic evaluation was performed one
limb at a time. When we saw narrowing of the graft limb in
association with external compression or angulation within
the proximal external iliac artery, we implanted a Wallstent.
Less concrete indications for adjunctive stenting
emerged as the study progressed. These included angula-
tion of the proximal common iliac artery on preoperative
imaging, angulation of the graft limb in the absence of
narrowing, and external iliac artery implantation. In cases
of angulation at or close to the end of the graft, the
additional Wallstent stent extended into the downstream
artery.
While in the hospital, patients underwent multiplanar
abdominal radiography and contrast-enhanced computed
tomography (CT) scans. Patients were then followed-up at
1 month, 6 months, and 1 year, and yearly thereafter with a
physical exam, contrast-enhanced CT, and multiplanar ab-
dominal radiography. Patients with postoperative evidence
of endograft limb compression, kinking, angulation, or
limb thrombosis underwent angiography and catheter-
based intervention. After thrombectomy or thrombolysis,
angiographically identifiable stenosis, kink, or angulation
were usually treated by using additional bare metal stents,
and the patient was followed-up according to the routine
imaging protocol.
Statistical analysis. Measured values are reported as
percentages or means  SD. The Student’s t test and
Fisher’s exact test were used to determine differences be-
tween groups. P .05 was considered significant. Survival,
primary patency, and patient freedom from limb thrombo-
sis were calculated by using life-table analysis and reported
with standard errors. The log rank test determined differ-
ences between life tables. Analyses were performed with
JMP software (version 5.0.1) (SAS Institute, Cary, NC).
RESULTS
Between 1999 and June 2004, 248 of the patients
treated with the Zenith AAA stent-graft had sufficient
imaging for inclusion in this retrospective review, and 64
had additional bare stent placement in endograft limbs at
the time of endovascular AAA repair. The remaining 184patients had no additional bare stents. The standard three-
component bifurcated Zenith stent-graft was used in 238
patients. Three patients in the stented group and seven
patients in the nonstented group underwent aneurysm
repair with a custom-made uniiliac version of the Zenith
stent-graft.
There were no limb occlusions in the stented group and
13 limb occlusions in 13 patients in the unstented group.
Thirty-eight percent of thrombosed limbs involved the
contralateral limb, and 62% involved the ipsilateral limb.
The overall rate of limb thrombosis in the total population
of 486 limbs was 2.7%. Mean follow up was 2.0 1.3 years
in the stented group and 2.0 1.4 years in the nonstented
group.
Patient demographics and risk factors for atherosclero-
sis are listed in Table I. There were 15 women (23%) and 49
men in the stented group, compared with 21 women (11%)
and 163 men in the unstented group (P  .02). By life-
table analysis, survival at 6 months, 1 year, and 3 years was
95%  3%, 87%  4%, and 61%  12%, respectively, in the
stented group compared with 98%  1%, 95%  2%, and
76%  4% in the unstented group (P  NS) (Fig 1). Four of
the 13 patients with limb thrombosis died during follow-
up. One death was secondary to infection of a femorofemo-
ral bypass 4 months after placement for a thrombosed
endograft limb. The other three deaths were unrelated to
graft occlusion and caused by aneurysm rupture (secondary
to a type II endoleak), cardiac disease, and pulmonary
disease.
At the initial operation, 64 patients had adjunctive
stents inserted in 85 endograft limbs. On retrospective
review of perioperative imaging, the primary indications for
adjunctive bare stent placement appear to have been en-
dograft limb angulation (34%), compression (41%), and
kinking (25%). Details of stent placement are listed in Table II.
Table I. Patient demographics
Adjunctive stents
(n  64) (%)
No stents
(n  184) (%)
Age (mean, years) 79  8 79  5
Female sex* 15 (23) 21 (11)
Risk factors
Smoking 33 (52) 108 (59)
COPD 16 (25) 57 (31)
Myocardial infarction 24 (38) 68 (37)
Congestive heart failure 12 (19) 35 (19)
Coronary artery disease 42 (66) 120 (65)
Hypertension 46 (72) 127 (69)
Diabetes mellitus 7 (11) 26 (14)
Cerebrovascular disease 12 (19) 40 (22)
Hyperlipidemia 33 (52) 101 (55)
Renal insufficiency 12 (19) 36 (20)
Coagulopathy 4 (6) 14 (8)
Previous vascular surgery 21 (33) 66 (36)
Mean maximum aneurysm
diameter (mm) 58  13 59  10
COPD, Chronic obstructive pulmonary disease.
*P .02.The nominal diameter of the bare stent used was 10 mm.
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April 2006664 Sivamurthy et alFig 1. Plain abdominal radiographs of a stent-graft show indications for adjunctive stent placement. A, Limb stenosis
(arrow) in the distal aspect of the stent graft limb. B (left panel), Preoperative angiography illustrates narrow distal aorta
and bifurcation. B (right panel), Palmaz stents (arrow) were placed in both stent graft limbs at the level of the narrow
distal aorta to maintain patency. C, Limb angulation (arrow). D, Limb kinking: combination of limb angulation with
reduction of luminal diameter.
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the external iliac artery. This includes eight (11%) of 85
stented limbs and 14 (4%) of 361 unstented limbs (P 
.01). Two of 14 unstented limbs subsequently occluded,
but all of the stented limbs remained patent.
Although no limbs in the stented group have occluded,
two patients have undergone additional treatment for
threatened occlusion. In one patient, kinking developed at
an unstented site, and another patient was found to have a
dissection of the external iliac artery. Both problems were
treated withWallstents. No complications have been attrib-
utable to adjunctive stents.
In the unstented population, 73% of occlusions oc-
curred 6 months of endovascular AAA repair. The mean
time to occlusion was 0.68  1.3 years. Reasons for occlu-
sion included angulation in 7 (54%), kinking in 3 (23%),
compression in 1, heparin-induced thrombocytopenia in 1,
and external iliac dissection in 1. Two patients had no
intervention because they were asymptomatic. Interven-
tions to restore perfusion in 11 patients included throm-
bectomy in 2, thrombectomy with bare stent placement
in 3, femorofemoral bypass in 4, thrombolysis in 1, and
thrombolysis with bare stent placement in 1 (Table III). Of
the seven who underwent thrombectomy or thrombolysis,
three had no additional stents placed at the secondary
procedure. Two of these three went on to rethrombose,
one at 4 months and the other at 2 years after the secondary
intervention to restore perfusion. Both then underwent
femorofemoral bypass.
By life-table analysis, primary patency was 100%  0%
at 6 months, 1 year, and 3 years in stented limbs, compared
with 97%  1%, 96%  1%, and 94%  3% in unstented
limbs (P  .05) (Fig 2). B y life-table analysis, patient
freedom from any limb thrombosis was 100%  0% at 6
months, 1 year, and 3 years in the stented patients, com-
pared with 94%  2%, 92%  4%, and 88%  5% in
Table II. Procedural characteristics
Adjunctive stent
(n  85) (%)
No stent
(n  361) (%)
Distal endograft limb fixation
Common iliac artery 65 (89) 347 (96)
External iliac artery* 8 (11) 14 (4)
Predeployment endograft
limb diameter (mm)* 13  3 16  4
Narrowest endograft limb
diameter (mm)
postdeployment 9.4  2
Stent type (64 patients;
85 limbs)
Palmaz 16 (25); 25 (29)
Wallstent 51 (80); 64 (75)
Bilateral 20 (31); 40 (47)
Mean stent diameter (mm) 12  2
Mean stent length (mm) 60  20
Mean balloon diameter (mm) 11  2
Mean number of stents 1.4  0.6
*P  .01.unstented patients (P  .05) (Fig 2).DISCUSSION
We found adjunctive bare metal stents to be safe and
effective for the prevention of limb thrombosis following
endovascular AAA repair with a Zenith stent-graft. No
stented limb thrombosed and no complications occurred
as a result of adjunctive stenting. All of these stents were
inserted to treat findings such as kinking and external
compression that are known to predispose to limb throm-
bosis.9 We conclude, for lack of an alternative explanation,
that the absence of subsequent thrombosis in these high-
risk patients was attributable to the presence of the addi-
tional stent.
What this retrospective review lacks is a control
group. We cannot say what the thrombosis rate would
have been had no patients been stented, or had stenting
been applied randomly. In this study we used the un-
stented patients for comparison, but they were certainly
not an unselected group. Indeed, they were left un-
stented at the time of operation because they were not
thought to be at high-risk for limb thrombosis. We
assume that this process of selection eliminated the
particularly high-risk patients and probably reduced the
overall thrombosis rate observed in the unstented group
in much the same way that the availability of endovascu-
lar repair improves the results of open surgery.
We recognize that the lack of a control group limits
our ability to interpret provocative findings such as the
high proportion of women among the stented group. We
believe that unfavorable anatomy in women produced
high rates of kinking or stent-graft compression, which
were identified at operation and treated with adjunctive
bare metal stents. Other authors have attributed gender-
related differences in the outcomes of endovascular an-
eurysm repair, including high rates of limb thrombosis,12
to a higher prevalence of unfavorable anatomy in
women. The absence of any difference between men and
women in overall thrombosis rate in our study may be a
consequence of the observed difference in the rate of
adjunctive stenting or of some previously unreported
characteristic of the Zenith stent-graft.
The disproportionate number of external iliac limbs in
the stented group probably represents our response to the
observation that a disproportionate number of external iliac
graft limbs thrombose7 in the absence of stents. Again, the
selective insertion of adjunctive stents has limited our abil-
ity to interpret the findings of this study. Nevertheless, we
now routinely insert Wallstents in cases of external iliac
artery implantation.
The current study provides no indication of what find-
ings warrant a stent and what affect such a policy would
have on overall thrombosis rates. From our findings, how-
ever, one can say that the additional stents are unlikely to
cause additional problems. It is only a question of time and
expense; hence, our current liberal approach to adjunctive
stenting.
Had we been able to identify and stent all at-risk
limbs, we would probably have had even less to report,
exter
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was not the case, it is clear that we still need a better way
to identify limbs that might benefit from additional
stents. For a variety of reasons, we were not able to
analyze the predictive value of preoperative CT, preop-
erative angiography, or intraoperative angiography as
determinants of thrombosis risk. Most preoperative CT
scans were not represented in three-dimensions but only
as a series of slices. Many patients did not have preoper-
ative angiography. The intraoperative angiograms were
not all saved to a file, and those that were saved were not
of uniform quality. The criteria for stenting varied be-
tween operators and evolved as the study progressed.
Even if we had been able to stratify risk according the
findings of high-quality preoperative and intraoperative
imaging, it is possible that other tests would still be
needed to further refine patient selection. Pullback pres-
Table III. Outcome of thrombosed limbs
No. Side
Distal
implant
Narrowest limb
diameter (mm)
Time to
thrombosis (yr)
1 C CIA 8 3.94
2 I CIA 11 0
3 I CIA 10 .01
4 I EIA 8 .12
5 I CIA 9 0
6 I CIA 8 1.05
7 C CIA 7 .04
8 C CIA 11 .01
9 I EIA 9 .04
10 I CIA 11 .6
11 C CIA 5 3.03
12 C CIA 10 .01
13 I CIA 11 .3
C, contralateral limb; I, ipsilateral limb; CIA, common iliac artery; EIA,
T, thrombectomy; Fem-fem, femorofemoral bypass; L, thrombolysis; HIT,
Fig 2. Life-table analysis for survival of stented and no
given in the table within the graft. Values are the meansure measurements, for example, can help identify hemo-dynamically significant lesions,5 but they are relatively
insensitive, even after flow through the femoral arteries
has been restored. Ultrasound may be more sensitive,13
but the test is expensive, time consuming, and of un-
known predictive value.
The current routine follow-up regimen appeared to
play little role in the prevention of limb thrombosis. We
identified and treated only two cases of impending limb
thrombosis, both in already-stented patients. The explana-
tion may lie in the timing of routine follow-up. Most cases
of graft thrombosis occurred 6 months of stent-graft
insertion, during which time the patients underwent rou-
tine imaging only once at 1 month.
CONCLUSION
Limb thrombosis is a rare, but preventable, source of
morbidity following endovascular aneurysm repair with the
Cause
thrombosis Intervention Initial outcome
Secondary
intervention
A T/stent 
HIT T  T/fem-fem
A Fem-fem 
A Fem-fem 
S T 
A None None
K T/stent 
K Fem-fem 
K L/stent  Fem-fem
A Fem-fem 
A None None
D T/stent 
A L 
nal iliac artery; A, severe angulation; K, kink; S, stenosis; D, dissection;
n-induced thrombocytopenia.
ted patients. The number of patients in each interval is
for all data points.nstenZenith stent-graft. Adjunctive stenting is effective prophy-
 SE
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remains problematic. Fig 3).
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Dr Farber. I would like to congratulate Dr. Sivamurthy on an
excellent presentation and thank the UCSF group for their pro-
vocative paper. In this retrospective analysis 248 abdominal aortic
aneurysm patients treated with the Zenith endograft were evalu-
ated. Those patients,who had underwent intraoperative adjunctive
bare metal stent placement to treat limb abnonnalities, were com-
pared to those in whom stents were not used. Reasons to stent
included limb angulation, compression, and kinking. There were
significantly more women in the stented group. A significant
proportion of the grafts that extended to the external iliac artery
were stented. Two external iliac artery limbs that were not stented
eventually occluded. During follow up there were no limb occlu-
sions in the stented group and 13 limb occlusions in the non-
stented group.
Themajor strength of this paper is that it brings up a topic that
has not been fully explored: Introperative management of an
endograft limb. Most of us would treat an obvious graft limb
deformity with angioplasty and possible stenting. But what about
minor limb deformities? It is not uncommon to see a minor
luminal abnormality on a completion angiogram in an endograft
limb and yet its treatment is not always obvious. This paper
demonstrates that use of bare-metal stents to treat limb abnormal-
ities is effective and safe.
The major weakness of this paper, which is well acknowledged
in the manuscript, is that the cohort in which bare-metal stents
were used lacked an adequate control group. Therefore some
conclusions drawn from this study may be difficult to interpret.
Clearly there are situations in which placement of a stent is appro-
priate. The lack of limb thromosis in the stented group only
underscores the correct decision on the part of the surgeons to
stent when a limb abnonnality was noted. What then can be said
about the non-stented limbs which went on to thrombose? Could
these events been possibly prevented by stent placement? It is clear
that angiography is not completely accurate in predicting which
endograft limbs need to be stented. Should other intraoperative
imaging techniques be routinely used? This paper brings up these
provocative issues and challenges us to design prospective studies
in an attempt to answer them.
I have several questions:
Dr Farber. 1. What exactly affected your decision to place a
stent? Was it only the obvious limb abnonnalities? Did you stent
any minor limb irregularities? What is your advice regarding man-
agement of a endograft limb which is noted on a completion
angiogram to have a minor non flow limiting stenosis or angula-
tion?
Dr Sivamurthy. The decision to stent varied from operator to
operator, and study period to study period. At the outset of the
study different surgeons applied different criteria. Since then we
have seen a convergence of views. We recognize that the subjectivepaper. Initially, our indications as a group to place stents in
endograft limbs were for limb stenosis, limb kinking, and narrow
aortic bifurcations. Over time, our indications have evolved and we
have become more liberal in our indications for stenting to include
limb angulation. The decision to place a stent was based predom-
inantly on completion angiography after all stiff guidewires were
removed. Minor limb irregularities seen on completion angiogra-
phy were selectively stented based on preoperative imaging. For
the endograft limb which has a minor non flow limiting stenosis or
angulation on completion angiogram, we would base our decision
to stent based on the preoperative imaging. If the iliac arteries had
significant tortuosity or disease preoperatively, we would stent the
limb with a minor limb irregularity. Furthermore, iliac artery
tortuosity and stenosis tends to reassert itself in the postoperative
period so that a mild irregularity seen on completion angiogram
may actually becomemore severe leading to limb thrombosis in the
postoperative period. Remember, most limb thromboses occurred
early within 6 months in this study and our current imaging
protocol at 1 month, 6 month, and yearly missed these impending
limb thromboses.
Dr Farber. 2. Intravascular Ultrasound (IVUS) has been
shown to identify endograft limb abnormalities that were missed
during angiography in Ancure endografts. Have you used IVUS in
your patients? Do you think IVUS should be used routinely?
We have not used IVUS in our patients. Although IVUS may
be more sensitive, we do not feel that it needs to be used routinely.
IVUS is expensive, time consuming, and of unknown predictive
value in trying to identify such a small population of limbs at risk
for thrombosis with “abnormalities missed during angiography.
Furthermore, this study illustrates bare stenting is simple, safe, and
effective when employing our liberal indications.
Dr Farber. 3. You identified two potentially high risk groups
for limb thrombosis: women and patients in whom endograft limbs
were extended into the external iliac artery. Is it your recommen-
dation that patients in these groups ought to be stented routinely?
We recommend bare stenting of all endograft limbs extended
into the external iliac artery. This represents our response to the
observation that a disproportionate number of external iliac graft
limbs thrombose in the absence of stents. We do not recommend
routinely stenting all women. This should be performed on a case
by case basis based on preoperative and intraoperative anatomy.
Unfavorable anatomy (smaller, tortuous vessels) in women prob-
ably lead to higher rates of kinking or stent graft compression and
explains our higher rate of stenting in this group.
Dr Farber. 4. Did you evaluate whether there was a correla-
tion between limb thrombosis and quantatative anatomical factors
such as minimal iliac diameter, iliac angulation, and degree of iliac
calcification?
Our prospective data collection did include an assessment of
iliac tortuosity. Unfortunately, this was rather subjective and in-
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angulation. We are not in a position to make these measurements
retrospectively because most of the CT scans were represented by
hard copy transaxial slices and many of the patients lacked preop-
erative angiograms. We cannot assess intraoperative findings, be-
cause the recorded completion angiograms are often limited to a
single AP view, especially in unstented cases. Intraoperative imag-
ing tended to be better in stented cases, because the additional
angiograms formed the basis for the decision to insert adjunctive
stents.
Even if we could measure these factors we would be unable to
correlate most of the highest risk cases with outcome because these
were the very ones that received additional stents, which may have
prevented thrombosis. We are unable to offer any specific recom-
mendations as to which limbs require adjunctive stenting. Based
on the findings of this study we can say that adjunctive stenting
appears to be safe and effective prophylaxis against graft limb
thrombosis, but we cannot say which patients are most at risk, or
how to apply a policy of selective stenting.
Dr Farber. 5. Finally, twelve out of the thirteen limb occlu-
sions appeared to have had an anatomical abnormality on postop-
erative imaging. Did you compare these studies with your intraop-
erative angiography studies to see if in retrospect the offending
lesion could be identified and the need to stent predicted?
Attempts were made to review the intraoperative angiography
studies to see if the offending lesion could be identified. Unfortu-
nately, these images were inadequate. Because a decision was made
not to place stents in these patients, the imaging was limited to an
AP view. Typically, when a decision is made to place a stent,
multiple oblique views are performed to define the anatomy.
Therefore, the offending lesion may have been present, but un-
identified at the time of operation. Another consideration is that
the lesions developed later as tortuosity of the native system
overwhelmed the stiffness of the limb. Furthermore, it would be
easy to miss subtle shifts in stent graft position on the one month
postoperative images that might progress slowly to produce
thrombosis before the six month interval when most limb throm-
bosis presented in this study.
Dr William Quinones. (Los Angeles, CA) I enjoyed your
presentation very much because I think this is an important prob-
lem. Given that the graft that you are using, the endograft that you
are using, is fully supported, we at UCLA have taken the position
that when we finish these grafts with angioplasty the limbs liberally,
not just as recommended by the company at the junctions and so
on, and our incidence of long-term limb thrombosis has been
extremely low. I mean I think we havemaybe 3 or 4 over the last 10
years. My first question is, do you angioplasty these areas that you
see either a kink or a defect before you stent or do you stent
primarily?
Dr Nayan Sivamurthy. (San Francisco, CA) We stented
primarily in all cases and then balloon angioplastied. From our
experience, stenting is required to correct the anatomic defect.
Initially, angioplasty alone may alleviate the defect. However, iliac
tortuosity tends to reassert itself and may predispose graft limbs to
develop kinking, angulation, or stenosis and subsequent limb
thrombosis on follow up. Therefore, we feel primary stenting is
indicated in the majority of cases.
Dr Quinones. So you haven’t tried just angiplastying the
process, because I can tell you that in our hands works very well. It
resolves 95% of the instances.
My second question is, it is curious to me that even in the cases
that you had long-term limb thrombosis in the unstented group,
even when you did thrombectomy or lysis in some of those cases
you did not stent. You just left it alone, so the question is would
having stented that limb initially prevented the thrombosis or how
do you explain the fact that you treated the thrombosis and didn’t
have to stent?
Dr Sivamurthy. At the time, the operating surgeon’s impres-
sion was that there was no anatomic lesion to treat. 7 of 13 patients
with limb thrombosis had no stent placed after interventions totreat the occlusion. 4 of the 7 patients with limb thrombosis
underwent extranatomic bypass which is a viable alternative. 2 of 7
patients had thrombectomy alone. One of these patients required
reintervention and extraanatomic bypass. One patient underwent
thrombolysis alone. Retrospective review of those incidences of
graft thrombosis where we did not place a stent during reinterven-
tion (7 of 13) an anatomic lesion could be appreciated. These seven
cases may have been amenable to a stent. However, the difficulty of
a retrospective review is trying to identify the operating surgeon’s
thought process.
Dr Ben Starnes. (Tacoma, WA) Two questions--one techni-
cal question and one philosophical question.
The technical question is, when you do your completion
angiography, do you do that with stiff wires in place or with soft
wires in place to allow for the tortuosity?
My second question is, you used 80%Wallstents to stent these
graft limbs and my question is why? There are better self-expand-
ing stents in my opinion. The Wallstent has frayed edges on the
end. I’m wondering if you’ve seen graft complications or erosions
into the graft material from the Wallstents. Do you use self-
expanding stents at the aortic bifurcation only andWallstents in the
tortuous portions? I was just wondering if you’d comment on that.
Dr Sivamurthy. Regarding the first question, we remove all
stiff guidewires before completion angiography.
Regarding the second question we primarily use theWallstent.
We have not seen any graft complications or erosions into the graft
material from the Wallstents. We feel the Wallstent has no sharp
points along its length to injure the body of the graft except at the
proximal and distal ends. We tend to place the wall stent so that the
top starts a little above the aortic bifurcation and the bottom of the
stent ends in native artery to minimize this part of the stent in
contact with the graft. We use the balloon expandable Palmaz stent
specifically when more radial force is required. An example would
be distal aortic narrowing due to calcification or prior aortic
surgery. We have not used any other self expanding stents
Discussion Audience: I just want to make some comments.
First of all it was a nice presentation. But we always tend to dwell on
the negatives of looking at limb thrombosis, but if you look at it the
other way you are talking about 500 limbs that were placed at risk
in 3 to 4 years and you had 13 limbs that are occluded. You are
talking about a very low limb thrombosis rate and I think that is
something that when we started, especially when I started doing
endografting years ago that I thought our limb thrombosis was
going to be much higher and I also thought that the external iliac
artery was going to be a problem as we put in this large device into
the external iliac artery. This was proven not to be the case in your
series and our series at Harvard. I mean the same thing, the
external iliac artery tolerates actually this manipulation very well. I
think what we are doing is we are _____ this vessel. Actually we are
improving our patency. In our patient population 25% of them end
up having an increase in their ABIs in the postoperative period, so
I think that is something that arises from it.
With regards to women, they continue to be a problem with
endografting. Being from the other spectrum of using intravascular
ultrasound in every case, what I find it is not so much the angula-
tion but the diameter. The vessels tend to be smaller. It may be that
is really an oversizing on the limbs rather than angulation.
The other comment I have is that I thought that when we did
have limb thrombosis that thrombolysis would be ideal for them
and that has not been the case. We end up doing a lot more
crossover fem-fems or mechanical thrombectomy in that area. This
is something that you also pointed out too.
My question though is when you get limb thrombosis late one
of the things that has been very useful—the group in Sidney has
pointed this out—is just looking at the x-rays before you submit
somebody to an angiogram and see those limb angulations. Could
you speculate, in the limb thromboses that occur late, was that due
in some way to the collapse of the aneurysm, reshaping the limb
entry into the limb and that might be the failure mode.Thank you very much.
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useful in displaying the limb anatomy and determining the cause
for limb thrombosis. This was our primarymode for identifying the
cause for limb thrombosis. Our postoperative surveillance includes
CT and plain films at 1 month, 6 month, 1 year, and then yearly
afterwards. Two patients developed limb angulation and subse-
quent thrombosis late that was not apparent on earlier imaging.
Retrospective review allowed us to appreciate this over time.You
can speculate that it may be secondary to aneurysm remodeling,
but I can not make that conclusion with certainty. More likely,
thrombosis is a result of iliac tortuosity reasserting itself in the
postoperative period. Remember, the majority of limb thrombosis
occurred early with 73% occluding within 6 months of endograft
placement. Limb thrombosis appears to be an early event. Postop-
erative imaging based on our protocol was not useful in detecting
early impending occlusion. Imaging may detect late impending
occlusions. However, late thrombosis appears to be a rare event
and involved only two patients in this study.
Dr Chuter. I’d like to just kind of clarify a couple of things,
what-was-in-the-mind-of-the-attending kind of things. One of
them relates to the use of the Wallstents. If you look at the big
European experience with earlier stent graft designs, you find that
some stents make holes in grafts and the bit of the stent that makes
the hole is the apex of the zigzag, and all of the stent alternatives
that are out there essentially consist of a series of zigzags. When
you put them around a corner, those little zigzags present out-
wards. They have sharp apices and they are potentially injurious to
grafts. The Wallstent doesn’t have any of those. It is continuous
wire from end to end. The only bits you have to worry about arethe top and the bottom. If you put the top sticking up a little bit
into the bifurcation and the bottom sticking a little bit down into
the artery, you don’t have any of that in contact with graft wall.
There are a couple of reports in the literature of the old EBT, the
Ancure device, getting injured byWallstents but it’s very, very rare.
Wallstent is quite a benign object. Our experience tends to bear
that out.
One of the other things relates to the late occurrence of
thrombosis. What we’ve tended to find is that anatomy reasserts
itself, that if you put a stiff stent graft, which the _____ stent graft
is rather stiff, through a tortuous limb, you can straighten it out.
Unfortunately, when you come back a month later the anatomy if
it was very tortuous has reasserted itself and now there is a kink. So
we have taken preoperative anatomy as something of an indication
of what postoperative anatomymaybe is not like in the OR but will
be like a little bit later, so we are more aggressive on that point of
view.
Just one comment that relates back to the data. One of the
most interesting findings I think Nayan dug up relates to the limbs
that weren’t stented in patients who had other stented limbs, so the
unstented side of a stented patient. Those limbs never thrombosed.
They had no stents in them and they never clotted off. The
question is why. I suggest that the answer is that the presence of a
stent in one limb is a marker for the surgeon and the surgeon who
is placing stents in one limb is going to perhaps be more likely to
place stents in another limb if that limb needs it, so perhaps we’re
seeing there what happens with a slightly more aggressive ap-
proach. I’ll tell you what happens, you don’t get any limb throm-
bosis. I’ll put that out as a hypothesis.
